Factors affecting efficacy of pegylated interferon alpha-2a in chronic hepatitis C patients with serotype 2-Reference-Cited by-同舟云学术

Factors affecting efficacy of pegylated interferon alpha-2a in chronic hepatitis C patients with serotype 2

Published:2011 Issue:4 Volume:52 Page:236-243
ISSN:0451-4203
Container-title:Kanzo
language:ja
Short-container-title:Kanzo

Author:

Irishio Keiko,Imai Yasuharu,Mita Eiji,Toyama Takashi,Kuzushita Noriyoshi,Nagase Toshihiko,Doi Yoshinori,Yamada Akira,Kato Michio,Fukuda Kazuto,Igura Takumi,Sawai Yoshiyuki,Kogita Sachiyo,Hiramatsu Naoki,Takehara Tetsuo,Hayashi Norio

Publisher

Japan Society of Hepatology

Subject

Hepatology

Link

http://www.jstage.jst.go.jp/article/kanzo/52/4/52_4_236/_pdf

Reference16 articles.

1. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

2. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

3. Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses

4. Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C

5. Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness analysis of sofosbuvir plus ribavirin in patients with genotype 2 chronic hepatitis C: an analysis with real world outcomes from a multicentre cohort in Japan;BMJ Open;2019-06

2. JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2;Hepatology Research;2016-02

3. Guidelines for the Management of Hepatitis C Virus Infection;Hepatology Research;2013-01